GTR Test Accession:
Help
GTR000026321.3
CAP
Last updated in GTR:
2024-10-02
View version history
GTR000026321.3,
last updated:
2024-10-02
GTR000026321.2,
last updated:
2023-09-25
GTR000026321.1,
registered in GTR:
2020-09-22
Last annual review date for the lab: 2024-10-02
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Pre-symptomatic
Conditions (1):
Help
Azorean disease
Genes (1):
Help
ATXN3 (14q32.12)
Methods (1):
Help
Molecular Genetics - Targeted variant analysis: Trinucleotide repeat by PCR or Southern Blot
Target population: Help
Genetic testing for the SCA panel is typically restricted to …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Isolated DNA
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Licensed Physician
Lab contact:
Help
Claudia Carriles, MS, Certified Genetic counselor, CGC, Genetic Counselor
[email protected]
204-787-4033
[email protected]
204-787-4033
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
4 mL EDTA whole blood; shipped at room temperature
Order URL
Order URL
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
Decline to answer
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test Order Code,
Test strategy
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 1
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Targeted variant analysis
Trinucleotide repeat by PCR or Southern Blot
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis;
Pre-symptomatic
Target population:
Help
Genetic testing for the SCA panel is typically restricted to neurologists and medical geneticists. Typically the patient meets one of the following criteria: 1) Patient diagnosed with cerebellar ataxia and has a family history suggesting an autosomal dominant pattern of inheritance. or 2) Patient diagnosed with cerebellar ataxia (negative family …
View more
Recommended fields not provided:
Clinical validity,
Clinical utility,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Comments:
Help
SCA panel available
This clinical service test is available to Canadian residents only
This clinical service test is available to Canadian residents only
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Accuracy (59/59) = 100%; Specificity (55/55) = 100%; Sensitivity (4/4) = 100%.
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
No
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
College of American Pathologists, CAP
Description of PT method: Help
Formal PT program (CAP) once per year. Informal interlaboratory exchange program once per year.
No
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
College of American Pathologists, CAP
Description of PT method: Help
Formal PT program (CAP) once per year. Informal interlaboratory exchange program once per year.
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Clinical resources:
Molecular resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.